GM27997
Fibroblast from Skin, Skin
Description:
ENCEPHALOPATHY OF CHILDHOOD (LENNOX-GASTAUT SYNDROME)
THAP DOMAIN CONTAINING 12
Repository
|
NIGMS Human Genetic Cell Repository
|
Subcollection |
Heritable Diseases PIGI Consented Sample |
Biopsy Source
|
Skin
|
Cell Type
|
Fibroblast
|
Tissue Type
|
Skin
|
Transformant
|
Untransformed
|
Sample Source
|
Fibroblast from Skin, Skin
|
Race
|
White
|
Ethnicity
|
Not Hispanic/Latino
|
Ethnicity
|
Scottish, English, Dutch, German
|
Country of Origin
|
USA
|
Family Member
|
4
|
Family History
|
N
|
Relation to Proband
|
father
|
Confirmation
|
Molecular characterization before cell line submission to CCR
|
Species
|
Homo sapiens
|
Common Name
|
Human
|
Remarks
|
|
PDL at Freeze |
6.36 |
Passage Frozen |
3 |
|
IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin Confirmed by LINE assay |
|
Gene |
THAP12 |
Chromosomal Location |
11q13.5 |
Allelic Variant 1 |
p.Pro277Thr; ENCEPHALOPATHY OF CHILDHOOD (LENNOX-GASTAUT SYNDROME) |
Identified Mutation |
c.829C>A (p.Pro277Thr) |
Remarks |
Whole genome sequencing revealed a heterozygous mutation in THAP12 resulting in a frameshift variant c.829C>A (p.Pro277Thr); reads were aligned to human genome build 38 (hg38); 11:76352321 G>T (hg38); 11:76063365 G>T (hg19).
LCL is GM27996; affected daughter #1 is GM27991 (LCL) and GM27993 (fibro); affected daughter #2 is GM27988 (LCL) and GM27990 (fibro). |
Cumulative PDL at Freeze |
6.36 |
Passage Frozen |
3 |
Split Ratio |
1:2 |
Temperature |
37 C |
Percent CO2 |
5% |
Percent O2 |
3% |
Medium |
Eagles Minimum Essential Medium with Earle's salts:Dulbecco's modified MEM with 2mM L-glutamine or equivalent |
Serum |
15% fetal bovine serum Not inactivated |
Supplement |
- |
|
|